GENEREX BIOTECHNOLOGY CORPORATION (OTCMKTS:GNBT) Files An 8-K Material Modification to Rights of … – Market Exclusive

Posted: Published on March 17th, 2017

This post was added by Dr P. Richardson

GENEREX BIOTECHNOLOGY CORPORATION (OTCMKTS:GNBT) Files An 8-K Material Modification to Rights of ...
Market Exclusive
Generex Biotechnology Corporation is a development-stage company. The Company is engaged primarily in the research and development of drug delivery systems and technologies. The Company is focused on its technology for the administration of ...

Read more:
GENEREX BIOTECHNOLOGY CORPORATION (OTCMKTS:GNBT) Files An 8-K Material Modification to Rights of ... - Market Exclusive

Related Posts
This entry was posted in Biotechnology. Bookmark the permalink.

Comments are closed.